Newly released emails from a scientific advisor to the Department of Health and Human Services, show he was pushing a herd immunity strategy for the coronavirus. Pfizer is negotiating a deal with the US government to provide more vaccine doses. And gene-editing technology known as CRISPR is showing promise as a potential
cure for sickle-cell anemia.
Hosted on Acast. See acast.com/privacy for more information.
